Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free
Armata Pharmaceuticals AMEX ARMP
$2.76 0.23 8.30%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free
Rating Finrange Index: 21 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

99.64M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
177.90M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
0.15
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
36.10M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-14.81 %
Upcoming events Armata Pharmaceuticals All events
No upcoming events scheduled
Overview Financials Key Metrics Dividends Industry overview Events

Stock chart Armata Pharmaceuticals

Stock analysis Armata Pharmaceuticals

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.

More
-1.38 -0.86
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.

More
-3.11 2.05
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.

More
-4.46 -0.64
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.

More
-1.96 0.24
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.

More
225.13 -87.14

Price change Armata Pharmaceuticals per year

2.56$ 6.39$
Min Max

Summary analysis Armata Pharmaceuticals

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Armata Pharmaceuticals

Revenue and net income Armata Pharmaceuticals

All parameters
Stock news Armata Pharmaceuticals All news
14 August 2023 в 18:15

Armata Pharmaceuticals Shares Rise 13% on Narrower 2Q Loss

14 August 2023 в 18:15

Armata Pharmaceuticals Shares Rise 13% on Narrower 2Q Loss

About company Armata Pharmaceuticals

Armata Pharmaceuticals Inc., a clinical-stage biotechnology company, focuses on the development of targeted bacteriophage therapeutics for the treatment of antibiotic-resistant infections worldwide. It develops its products using its proprietary bacteriophage-based technology. The company's product candidates include AP-SA02 for the treatment of Staphylococcus aureus bacteremia; AP-PA02 for the treatment of Pseudomonas aeruginosa; and AP-PA03 for the treatment of pneumonia. It has a partnership agreement with Merck & Co. for developing proprietary synthetic phage candidates to target undisclosed infectious disease agents. The company is headquartered in Marina del Rey, California.
Address:
4503 Glencoe Avenue, Marina del Rey, CA, United States, 90292
Company name: Armata Pharmaceuticals
Issuer ticker: ARMP
ISIN: US04216R1023
Country: USA
Exchange: AMEX
Currency: $
IPO date: 2011-03-09
Sector: Healthcare
Industry: Biotechnology
Site: https://www.armatapharma.com

On which stock exchange are Armata Pharmaceuticals (ARMP) stocks traded?

Armata Pharmaceuticals (ARMP) stocks are traded on AMEX.

What is the ticker of Armata Pharmaceuticals stocks (ARMP)?

The stock ticker of Armata Pharmaceuticals’s stocks or in other words, the code is ARMP. The stocks are currently listed on the AMEX exchange.

In which sector and industry does Armata Pharmaceuticals (ARMP) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Armata Pharmaceuticals (ARMP) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Armata Pharmaceuticals (ARMP) stocks traded?

Armata Pharmaceuticals (ARMP) stocks are traded on the AMEX exchange in dollars.

What is the price of Armata Pharmaceuticals (ARMP) stocks today?

The current price of Armata Pharmaceuticals stocks on 29.04.2024 is 2.76 dollars. per share.

What is the dynamics of Armata Pharmaceuticals (ARMP) stocks from the beginning of the year?

Armata Pharmaceuticals (ARMP) quotes have increased by -10.97% from the beginning of the year up to 2.76 dollars. per 1 stocks.

How much did Armata Pharmaceuticals (ARMP) stocks increase in апреле 2024?

This month Armata Pharmaceuticals (ARMP) quotes have increased by -29.23% to 2.76 dollars. per share.

How much are Armata Pharmaceuticals (ARMP) stocks worth?

Today, on October, 29.04.2024 Armata Pharmaceuticals’s (ARMP) stocks cost 2.76 dollars..

What is the market capitalization of Armata Pharmaceuticals (ARMP)?

Capitalization is the market value of Armata Pharmaceuticals (ARMP) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 29.04.2024, the market capitalization of Armata Pharmaceuticals (ARMP) is estimated at about 99638398 dollars.